C Jamin1, P M Lydyard, R Le Corre
1Brest University Medical School, France.
CD5 and surface IgM (sIgM) co-cap and co-modulate on B cells. Protein tyrosine kinase inhibitors affect sIgM capping, while PKC pathways differentially regulate CD5 and sIgM modulation.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: